Ligand id: 8407

Name: etrolizumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9290 etrolizumab
PRO145223 | RG-7413 | RG7413 | rhuMAb Beta7
Etrolizumab is a humanized monoclonal antibody targeting integrin receptors containing the ITGB7 (β7) subunit (namely α4β7 and αEβ7).
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record. Peptide sequence matches indicate that US7528236 is the covering patent [4]. The likely candidate antibody clone is that designated hu504.32R.
Database Links
Specialist databases
IMGT/mAb-DB 362
Other databases
GtoPdb PubChem SID 252166617
Search PubMed clinical trials etrolizumab
Search PubMed titles etrolizumab
Search PubMed titles/abstracts etrolizumab
Wikipedia Etrolizumab